A novel donor splice site characterized by CFTR mRNA analysis induces a new pseudo-exon in CF patients

Journal of Cystic Fibrosis

Volumn 9, Issue 6, 2010, Pages 411-418

  Costantino, Lucy ^a   Claut, Laura ^a   Paracchini, Valentina ^a   Coviello, Domenico A ^a   Colombo, Carla ^a   Porcaro, Luigi ^a   Capasso, Patrizia ^a   Zanardelli, Maddalena ^a   Pizzamiglio, Giovanna ^a   Degiorgio, Dario ^a   Seia, Manuela ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

CFTR; Cystic fibrosis; MRNA; Pseudo exon; Splicing

Indexed keywords

MESSENGER RNA; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ALLELE; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; DNA DETERMINATION; EXON; GENE INSERTION; HUMAN; INTRON; NUCLEOTIDE SEQUENCE; POINT MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SPLICING;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXONS; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; POINT MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICE SITES; RNA, MESSENGER;

EID: 78650224343     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2010.08.009     Document Type: Article

References (27)

1. Southern K.W., Munck A., Pollitt R., Travert G., Zanolla L., Dankert-Roelse J., et al. ECFS CF Neonatal Screening Working Group. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 2007, 6(1):57-65.
2. Faà V., Incani F., Meloni A., Corda D., Masala M., Baffico A.M., et al. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. J Biol Chem 2009, 284:30024-30031.
3. Souza-Menezes J., Tukaye D.N., Novaira H.J., Guggino W.B., Morales M.M. Small nuclear RNAs U11 and U12 modulate expression of TNR-CFTR mRNA in mammalian kidneys. Cell Physiol Biochem 2008, 22:93-100.
4. Buratti E., Stuani C., De Prato G., Baralle F.E. SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer. Nucleic Acids Res 2007, 35:4359-4368.
5. Zhang X.H., Leslie C.S., Chasin L.A. Dichotomous splicing signals in exon flanks. Genome Res 2000, 15:768-779.
6. Sun H., Chasin L.A. Multiple splicing defects in an intronic false exon. Mol Cell Biol 2000, 20:6414-6425.
7. Eperon L.P., Graham I.R., Griffiths A.D., Eperon I.C. Effects of RNA secondary structure on alternative splicing of pre-mRNA: is folding limited to a region behind the transcribing RNA polymerase?. Cell 1998, 54:393-401.
8. Ishii S., Nakao S., Minamikawa-Tachino R., Desnick R.J., Fan J.Q. Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. Am J Hum Genet 2002, 70:994-1002.
9. Buratti E., Baralle M., Baralle F.E. Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res 2006, 34:3494-3510.
10. Pagani F., Buratti E., Stuani C., Bendix R., Dörk T., Baralle F.E. A new type of mutation causes a splicing defect in ATM. Nat Genet 2002, 30:426-429.
11. Highsmith W.E., Burch L.H., Zhou Z., Olsen J.C., Boat T.E., Spock A., et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 1994, 331:974-980.
12. Krawczak M., Reiss J., Cooper D.N. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992, 90:41-54.
13. Harris C.M., Mendes F., Dragomir A., Doull I.J., Carvalho-Oliveira I., Bebok Z., et al. Assessment of CFTR localisation in native airway epithelial cells obtained by nasal brushing. J Cyst Fibros 2004, 3:43-48.
14. Ramalho A.S., Beck S., Farinha C.M., Clarke L.A., Heda G.D., Steiner B., et al. Methods for RNA extraction, cDNA preparation and analysis of CFTR transcripts. J Cyst Fibros 2004, 3:11-15.
15. Reese M.G., Eeckman F.H., Kulp D., Haussler D. Improved splice site detection in Genie. J Comput Biol 1997, 4(3):311-323.
16. Cartegni L., Wang J., Zhu Z., Zhang M.Q., Krainer A.R. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 2003, 31:3568-3571.
17. Liu X.Z., Xia X.J., Adams J., Chen Z.Y., Welch K.O., Tekin M., et al. Mutations in GJA1 (connexin 43) are associated with non-syndromic autosomal recessive deafness. Hum Mol Genet 2001, 10(25):2945-2951.
18. Paracchini V., Seia M., Coviello D., Porcaro L., Costantino L., Capasso P., et al. Molecular and clinical features associated with CFTR gene rearrangements in Italian population: identification of a new duplication and recurrent deletions. Clin Genet 2008, 73:346-352.
19. Faà V., Bettoli P.P., Demurtas M., Zanda M., Ferri V., Cao A., et al. A new insertion/deletion of the cystic fibrosis transmembrane conductance regulator gene accounts for 3.4% of cystic fibrosis mutations in Sardinia: implications for population screening. J Mol Diagn 2006, 8:499-503.
20. Brogna S., Wen J. Nonsense-mediated mRNA decay (NMD) mechanisms. Nat Struct Mol Biol 2009, 16(2):107-113.
21. Pagani F., Buratti E., Stuani C., Romano M., Zuccato E., Niksic M., et al. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a non-evolutionary conserved intronic element. J Biol Chem 2000, 275:21041-21047.
22. Buratti E., Dörk T., Zuccato E., Pagani F., Romano M., Baralle F.E. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 2001, 20:1774-1784.
23. Steiner B., Truninger K., Sanz J., Schaller A., Gallati S. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in non mutated CFTR alleles. Hum Mutat 2004, 24:120-129.
24. Graveley B.R. Sorting out the complexity of SR protein functions. RNA 2000, 6:1197-1211.
25. Zuccato E., Buratti E., Stuani C., Baralle F.E., Pagani F. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing. J Biol Chem 2004, 279:16980-16988.
26. Chu C.S., Trapnell B.C., Curristin S., Cutting G.R., Crystal R.G. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet 1993, 3:151-156.
27. Buratti E., Brindisi A., Pagani F., Basile F.E. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am J Hum Genet 2004, 74:1322-1325.